A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab.
Saito N, Hatanaka T, Nakano S, Hazama Y, Yoshida S, Hachisu Y, Tanaka Y, Yoshinaga T, Kashiwabara K, Kubo N, Hosouchi Y, Tojima H, Kakizaki S, Uraoka T.
Saito N, et al. Among authors: tojima h.
Clin Case Rep. 2022 Jul 25;10(7):e6129. doi: 10.1002/ccr3.6129. eCollection 2022 Jul.
Clin Case Rep. 2022.
PMID: 35898742
Free PMC article.